ICH M10 draft [Regulatives / Guidelines]

posted by wienui  – Germany, Oman, 2019-03-13 18:06 (927 d 14:03 ago) – Posting: # 20023
Views: 3,801

Dear all,

"New or Alternative Technologies" an interesting part in the newly issued draft of BIOANALYTICAL METHOD VALIDATION, ICH M10 which Endorsed on 26 February 2019.

- When a new or alternative technology is used as the sole bioanalytical technology from the onset of drug development, cross-validation with an existing technology is not required.
Cross-validation but required when using two different bioanalytical technologies for the development of a drug.

on the other hand, The use of two methods or technologies within a
comparative BA/BE study is strongly discouraged:. (i.e not applicable at all also with cross-validation).:confused::confused:
Why ??

Best regards,

Edit: Post moved. [Helmut]


Complete thread:

 Admin contact
21,700 posts in 4,538 threads, 1,542 registered users;
online 2 (0 registered, 2 guests [including 2 identified bots]).
Forum time: Sunday 09:10 CEST (Europe/Vienna)

A central lesson of science is that to understand complex issues
(or even simple ones), we must try to free our minds of dogma and
to guarantee the freedom to publish, to contradict, and to experiment.
Arguments from authority are unacceptable.    Carl Sagan

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz